Karen Frascello
Senior Director - Medical Affairs, Expanded Access & Global Diagnostics Alnylam
Karen Frascello is Senior Director of Medical Affairs, Expanded Access and Global Diagnostics, with extensive experience in expanded and global access programmes. Her background includes work across pharmaceutical access, rare diseases and patient access, alongside previous leadership in business development and marketing for global access programmes. She has also contributed to the rare disease community through her involvement with Global Genes’ Patient Access Committee.
Seminars
Tuesday 23rd March 2027
Workshop F – From Access to Exit: Designing Global Program Closure, Patient Transition & Long-Term Access Strategies
1:30 pm
- Navigating country-by-country closure requirements, reimbursement delays and differing patient continuity obligations across global markets.
- Determining how and when programs should close in markets where launch plans, regulatory outcomes or funding assumptions change.
- Learning from successful and unsuccessful program exits, including the operational, regulatory and stakeholder challenges that emerge once an access program reaches the end of its lifecycle.
- Benchmarking how organizations are handling program winddown, patient communications, physician engagement and long-term access commitments globally
